0001493152-18-008648.txt : 20180613
0001493152-18-008648.hdr.sgml : 20180613
20180613215519
ACCESSION NUMBER: 0001493152-18-008648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180611
FILED AS OF DATE: 20180613
DATE AS OF CHANGE: 20180613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHUMACHER RICHARD T
CENTRAL INDEX KEY: 0001033775
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38185
FILM NUMBER: 18897989
MAIL ADDRESS:
STREET 1: 375 WEST STREET
CITY: WEST BRIDGEWATER
STATE: MA
ZIP: 02379
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000830656
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042652826
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
BUSINESS PHONE: 5082301828
MAIL ADDRESS:
STREET 1: 14 NORFOLK AVENUE
CITY: SOUTH EASTON
STATE: MA
ZIP: 02375
FORMER COMPANY:
FORMER CONFORMED NAME: BOSTON BIOMEDICA INC
DATE OF NAME CHANGE: 19960812
4
1
form4.xml
X0306
4
2018-06-11
0
0000830656
PRESSURE BIOSCIENCES INC
PBIO
0001033775
SCHUMACHER RICHARD T
130 LAKE RIDGE DRIVE
TAUNTON
MA
02780
1
1
0
0
President, CEO
SERIES AA CONVERTIBLE PREFERRED STOCK
2.50
2018-06-11
4
J
0
8.8
2500
A
2018-06-11
2019-06-11
COMMON STOCK
8800
8.8
D
COMMON STOCK WARRANT
3.50
2018-06-11
4
J
0
8800
A
2018-06-11
2023-06-11
COMMON STOCK
8800
8800
D
COMMON STOCK WARRANT
3.50
2018-06-11
4
J
0
1191
A
2016-03-31
2021-03-31
COMMON STOCK
1191
1191
D
On June 11, 2018, Pressure BioSciences, Inc. (the "Issuer") entered into a letter agreement with Mr. Schumacher (the "Reporting Person"). The Reporting Person previously held a convertible debenture with a face value of $22,000 (the "Debenture") and warrants to purchase common stock (the "Debenture Warrants"). Pursuant to the letter agreement, the Reporting Person agreed to convert the principal due to him pursuant to the Debenture into shares of Series AA Convertible Preferred Stock with a conversion price of $2.50 per share. The Reporting Person was also: (a) issued amended Debenture Warrants (originally issued on March 31, 2016) such that the exercise price is now $3.50 per share; and (b) issued a new warrant with an exercise price of $3.50 per share to purchase such number of shares of common stock as equal 100% of the number of shares of common stock issuable upon conversion of the Series AA Convertible Preferred Stock shares received as a result of the Debenture conversion.
/s/ Richard T Schumacher
2018-06-13